Does the media prefer MMED or KMTS?

In the previous week, Kestra Medical Technologies had 26 more articles in the media than MiniMed Group. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.29 beat Kestra Medical Technologies' score of 0.01 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer KMTS or LIVN?

In the previous week, Kestra Medical Technologies had 15 more articles in the media than LivaNova. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 16 mentions for LivaNova. LivaNova's average media sentiment score of 1.41 beat Kestra Medical Technologies' score of 0.01 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 8 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer IRTC or KMTS?

In the previous week, Kestra Medical Technologies had 25 more articles in the media than iRhythm Technologies. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.02 beat Kestra Medical Technologies' score of 0.01 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HAE or KMTS?

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Haemonetics. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 11 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.74 beat Kestra Medical Technologies' score of 0.01 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ITGR or KMTS?

In the previous week, Integer had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 35 mentions for Integer and 31 mentions for Kestra Medical Technologies. Integer's average media sentiment score of 0.75 beat Kestra Medical Technologies' score of 0.01 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 16 Very Positive mention(s) 2 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Kestra Medical Technologies (KMTS) Competitors

$25.06 -0.87 (-3.36%)

Closing price 04:00 PM Eastern

Extended Trading

$24.91 -0.15 (-0.60%)

As of 04:10 PM Eastern

Compare

KMTS vs. MMED, LIVN, IRTC, HAE, and ITGR

Should you buy Kestra Medical Technologies stock or one of its competitors? MarketBeat compares Kestra Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kestra Medical Technologies include MiniMed Group (MMED), LivaNova (LIVN), iRhythm Technologies (IRTC), Haemonetics (HAE), and Integer (ITGR). These companies are all part of the "healthcare equipment" industry.

How does Kestra Medical Technologies compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

MiniMed Group presently has a consensus target price of $21.62, suggesting a potential upside of 16.46%. Kestra Medical Technologies has a consensus target price of $27.83, suggesting a potential upside of 11.07%. Given MiniMed Group's stronger consensus rating and higher possible upside, research analysts clearly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -138.35%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

In the previous week, Kestra Medical Technologies had 26 more articles in the media than MiniMed Group. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.29 beat Kestra Medical Technologies' score of 0.01 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kestra Medical Technologies	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

19.7% of MiniMed Group shares are owned by institutional investors. 2.2% of MiniMed Group shares are owned by company insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Kestra Medical Technologies has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.68	-$190.97M	-$0.68	N/A
Kestra Medical Technologies	$95.13M	15.44	-$131.61M	-$2.42	N/A

Summary

MiniMed Group beats Kestra Medical Technologies on 10 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to LivaNova?

Kestra Medical Technologies (NASDAQ:KMTS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

LivaNova has a net margin of 7.48% compared to Kestra Medical Technologies' net margin of -138.35%. LivaNova's return on equity of 16.48% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
LivaNova	7.48%	16.48%	7.59%

97.6% of LivaNova shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Kestra Medical Technologies presently has a consensus target price of $27.83, suggesting a potential upside of 11.07%. LivaNova has a consensus target price of $83.50, suggesting a potential upside of 6.86%. Given Kestra Medical Technologies' higher probable upside, research analysts clearly believe Kestra Medical Technologies is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Kestra Medical Technologies had 15 more articles in the media than LivaNova. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 16 mentions for LivaNova. LivaNova's average media sentiment score of 1.41 beat Kestra Medical Technologies' score of 0.01 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	8 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kestra Medical Technologies has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Kestra Medical Technologies has higher earnings, but lower revenue than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	15.44	-$131.61M	-$2.42	N/A
LivaNova	$1.39B	3.09	-$242.47M	$1.95	40.07

Summary

LivaNova beats Kestra Medical Technologies on 12 of the 17 factors compared between the two stocks.

How does Kestra Medical Technologies compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

iRhythm Technologies has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

iRhythm Technologies presently has a consensus target price of $184.71, suggesting a potential upside of 48.36%. Kestra Medical Technologies has a consensus target price of $27.83, suggesting a potential upside of 11.07%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe iRhythm Technologies is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

iRhythm Technologies has a net margin of -3.53% compared to Kestra Medical Technologies' net margin of -138.35%. iRhythm Technologies' return on equity of -10.26% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

iRhythm Technologies has higher revenue and earnings than Kestra Medical Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.48	-$44.55M	-$0.86	N/A
Kestra Medical Technologies	$95.13M	15.44	-$131.61M	-$2.42	N/A

In the previous week, Kestra Medical Technologies had 25 more articles in the media than iRhythm Technologies. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.02 beat Kestra Medical Technologies' score of 0.01 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

iRhythm Technologies beats Kestra Medical Technologies on 12 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Haemonetics?

Haemonetics (NYSE:HAE) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Haemonetics has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	2.86	$97.31M	$2.02	41.49
Kestra Medical Technologies	$95.13M	15.44	-$131.61M	-$2.42	N/A

Haemonetics has a net margin of 7.29% compared to Kestra Medical Technologies' net margin of -138.35%. Haemonetics' return on equity of 27.30% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.29%	27.30%	9.59%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

99.7% of Haemonetics shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Haemonetics has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Haemonetics. MarketBeat recorded 31 mentions for Kestra Medical Technologies and 11 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.74 beat Kestra Medical Technologies' score of 0.01 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Haemonetics presently has a consensus price target of $78.89, indicating a potential downside of 5.86%. Kestra Medical Technologies has a consensus price target of $27.83, indicating a potential upside of 11.07%. Given Kestra Medical Technologies' higher probable upside, analysts plainly believe Kestra Medical Technologies is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Haemonetics beats Kestra Medical Technologies on 12 of the 17 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Integer?

Integer (NYSE:ITGR) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Integer has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86B	2.29	$102.81M	$4.01	31.15
Kestra Medical Technologies	$95.13M	15.44	-$131.61M	-$2.42	N/A

Integer has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

99.3% of Integer shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Integer had 4 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 35 mentions for Integer and 31 mentions for Kestra Medical Technologies. Integer's average media sentiment score of 0.75 beat Kestra Medical Technologies' score of 0.01 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	16 Very Positive mention(s)	2 Positive mention(s)	12 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer presently has a consensus target price of $109.86, suggesting a potential downside of 12.06%. Kestra Medical Technologies has a consensus target price of $27.83, suggesting a potential upside of 11.07%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Kestra Medical Technologies is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Integer has a net margin of 6.97% compared to Kestra Medical Technologies' net margin of -138.35%. Integer's return on equity of 12.77% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.77%	6.48%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

Summary

Integer beats Kestra Medical Technologies on 11 of the 16 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KMTS vs. The Competition

Export

Metric	Kestra Medical Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.47B	$5.65B	$6.90B	$12.86B
Dividend Yield	N/A	1.78%	2.60%	10.00%
P/E Ratio	-10.36	23.39	280.82	25.41
Price / Sales	15.44	43.83	599.65	90.78
Price / Cash	N/A	32.60	72.11	49.40
Price / Book	5.63	6.03	12.95	6.08
Net Income	-$131.61M	$151.74M	$3.49B	$348.07M
7 Day Performance	10.15%	4.81%	3.57%	4.71%
1 Month Performance	-7.12%	-0.15%	-2.50%	-2.12%
1 Year Performance	58.01%	8.50%	73.94%	20.58%

Kestra Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KMTS Kestra Medical Technologies	1.6757 of 5 stars	$25.06 -3.4%	$27.83 +11.1%	+67.4%	$1.47B	$95.13M	N/A	300	Insider Trade
MMED MiniMed Group	2.2859 of 5 stars	$18.05 -0.6%	$21.62 +19.8%	N/A	$5.07B	$3.10B	N/A	8,000
LIVN LivaNova	3.0502 of 5 stars	$80.14 -1.1%	$81.38 +1.5%	+99.5%	$4.45B	$1.39B	41.10	3,300	Trending News Earnings Report Analyst Forecast
IRTC iRhythm Technologies	4.2857 of 5 stars	$117.17 -1.6%	$184.71 +57.6%	-22.9%	$3.91B	$747.14M	N/A	2,400	Positive News Upcoming Earnings
HAE Haemonetics	2.2998 of 5 stars	$85.51 +0.8%	$78.89 -7.7%	+11.9%	$3.85B	$1.33B	42.33	3,009	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KMTS) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. MMED, LIVN, IRTC, HAE, and ITGR

How does Kestra Medical Technologies compare to MiniMed Group?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Summary

How does Kestra Medical Technologies compare to Haemonetics?

Summary

How does Kestra Medical Technologies compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. MMED, LIVN, IRTC, HAE, and ITGR

How does Kestra Medical Technologies compare to MiniMed Group?

Do analysts rate MMED or KMTS?

Is MMED or KMTS more profitable?

Does the media prefer MMED or KMTS?

Do insiders & institutionals hold more shares of MMED or KMTS?

Which has stronger valuation & earnings, MMED or KMTS?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Is KMTS or LIVN more profitable?

Do insiders and institutionals have more ownership in KMTS or LIVN?

Do analysts prefer KMTS or LIVN?

Does the media prefer KMTS or LIVN?

Which has more volatility & risk, KMTS or LIVN?

Which has stronger earnings & valuation, KMTS or LIVN?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Which has more risk & volatility, IRTC or KMTS?

Do analysts recommend IRTC or KMTS?

Is IRTC or KMTS more profitable?

Which has higher valuation & earnings, IRTC or KMTS?

Does the media prefer IRTC or KMTS?

Summary

How does Kestra Medical Technologies compare to Haemonetics?

Which has stronger earnings and valuation, HAE or KMTS?

Is HAE or KMTS more profitable?

Do insiders & institutionals believe in HAE or KMTS?

Which has more volatility and risk, HAE or KMTS?

Does the media favor HAE or KMTS?

Do analysts recommend HAE or KMTS?

Summary

How does Kestra Medical Technologies compare to Integer?

Which has better valuation & earnings, ITGR or KMTS?

Which has more volatility & risk, ITGR or KMTS?

Do insiders and institutionals hold more shares of ITGR or KMTS?

Does the media prefer ITGR or KMTS?

Do analysts recommend ITGR or KMTS?

Is ITGR or KMTS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools